suplatast tosilate has been researched along with Rhinitis, Allergic, Seasonal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, T; Nagakura, T; Ogino, S; Okubo, K; Sato, N; Takahashi, M | 1 |
1 trial(s) available for suplatast tosilate and Rhinitis, Allergic, Seasonal
Article | Year |
---|---|
Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
Topics: Adult; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arylsulfonates; Asian People; Double-Blind Method; Female; Humans; Immunoglobulin E; Japan; Male; Middle Aged; Omalizumab; Pollen; Rhinitis, Allergic, Seasonal; Sulfonium Compounds; Treatment Outcome | 2008 |